🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Breaking News! Score one for the good guys. US Supreme Court rules against administration attempt to defund Lung Cancer Screening, universally accepted as life-saving by identifying lung cancer at an early stage, when most curable. ASCO IASLC

#HawaiiLung25 Back to back excellent presentations by Logan Roof, MD, MS The James and Anjali Rohatgi Siteman Cancer Center on new therapies for #mesothelioma- w a focus on #volrustomig (bispecific PD1/CTLA4) DAVA Oncology

Check out this exciting new study led by Matthew Smeltzer Raymond Osarogiagbon, MBBS, FACP in JAMA Network Open!! Changing the USPSTF lung screening criteria from a 20-pack-year cutoff to a 20-year duration cutoff (Potter Criteria) greatly increases access to screening while maintaining screening

What an experience to present in #Hawaii with DAVA Oncology at #DAVALung ! Grateful for the opportunity, the science, the friendships, and the memories.❤️🫁😘

Published nature : Air pollution may drive TP53 and other mutations in lung cancer among never-smokers. EGFR was common in East Asia, KRAS in the West; secondhand smoke showed minimal genomic impact, and herbal toxin–linked signatures were seen in Taiwan.

⭐️A fantastic, balanced, and comprehensive editorial from Roberto Ferrara & colleagues - they do an elegant job dissecting many of my concerns with the state of IO clinical trial development. KEY POINTS: 1️⃣ Not all ICIs are equivalent & bind to varied epitopes. While single

"If funding is diminished, it will be catastrophic to millions of patients and families who will experience the devastation of cancer in the coming years." Richard J Boxer discusses the effect of decreased funding for cancer research in the US. ja.ma/4lHJdiB

Honored and humbled to accept a new role as Division Chief for Hematology & Oncology at Georgetown starting next month. Excited for all that the future holds for Georgetown University Georgetown Lombardi with the best colleagues one could ask for.

1st Edition Ying & Yang Lung Cancer Masterclass Organized by Mihaela Aldea Biagio Ricciuti, MD, PhD Roberto Ferrara Today - Fellows Workshop Team 4 with Dr. Lin

Jennifer A. Marks, MD wonderful case presentation about SMARCA4 deficient PDL1 95% resectable NSCLC opening the floor for Santiago Figueroa versus Andrea R. Filippi debate 'Surgery versus radiotherapy in resectable NSCLC' at #Yin&Yang Masterclass 2025 in Milan Mihaela Aldea Biagio Ricciuti, MD PhD

Debating my ALK sister today at the Ying & Yang Lung Cancer Masterclass in Milan, Italy ALK Positive ALK+ International Young Lung Cancer Initiative

Excited to be at the Yin & Yang Lung Cancer Masterclass organized by Mihaela Aldea Roberto Ferrara Biagio Ricciuti, MD, PhD. Innovative roundtable on clinical trial design + engaging & informative workshop/article discussions. Honored to be in Milan at the 1st Ed of this amazing conference

Enjoyed participating in the session on adjuvant #EGFR & #ALK TKI at Yin & Yang Lung Cancer Masterclass w/ Dr. Antonio Calles 🫁🚭 & Mariana Brandao w/ important debate on role of adjuvant chemo prior to TKI. Thanks to Mihaela Aldea Roberto Ferrara Biagio Ricciuti, MD, PhD for the chance to present!

Honored to participate in a vibrating series of debates in hot topics in lung cancer. Very inspiring for young oncologists and really challenging for the faculty to keep it fair and funny. Great initiative and bold format. Congrats for the success!! 👏 Roberto Ferrara

🌓Yin&Yang Masterclass 2025 1st edition comes to an end. Huge thanks to all young and early-career investigators for stepping up, and to the stellar faculty for guiding them with passion and vision. Next stop: Paris 2026 🇨🇵 Stay tuned! #YinYang2025 Mihaela Aldea Biagio Ricciuti, MD, PhD

Brilliant event with dynamic debates, meaningful discussions on how we interpret clinical studies and great conversations with colleagues from all over! Huge thanks to Roberto Ferrara Mihaela Aldea and Biagio Ricciuti, MD, PhD for organising such a fresh and engaging meeting! #YinYang2025

Honored to be part of the Yin&Yang Lung Cancer Masterclass in Milan 🇮🇹 Presented a case on EGFR-mutant NSCLC, had the chance to see a great debate led by Julia Rotow MD and Benjamin Besse and connected with young oncologists from around the world.

Milano was full of knowledge, fearless debates and mentorship. Thank you to the organizing committee for the invitation Biagio Ricciuti, MD, PhD Mihaela Aldea and Roberto Ferrara Day #1 workshop with fellows Day #2 Debate

The management of brain metastases in EGFR-variant and ALK-positive NSCLC patients remains uncertain, with evidence suggesting that upfront stereotactic radiosurgery (SRS) offers better local control and delays CNS progression. ja.ma/4k5ldos @Pike_lab

Cassio Murilo T. Hidalgo Filho Julia Rotow MD Benjamin Besse Roberto Ferrara Biagio Ricciuti, MD PhD Mihaela Aldea We would like to inform you that your post has been published on OncoDaily. Thank you for sharing. oncodaily.com/blog/cassio-mu…